Pentax obtains EU approval for single-use scope

EU authorities have given the CE mark to medtech firm Pentax's single-use bronchoscope which sets out to challenge Ambu's dominant position in the area.

Pentax CEO Fumio Urano and Hoya Corporation CEO Hiroshi Suziki shake hands

Japanese medtech firm Pentax is poised to enter the European market with a single-use bronchoscope called Pulmoone after having obtained a CE mark for the product, according to a company press release.

Bronchoscopes are used to examine the inside of the airways and lungs, and for many years, Ambu has dominated the market for single-use products in the area.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs